Trial intelligence / Profile preview

COL-101 vs Doxycycline 100mg in Rosacea

NCT00495313Phase 4Completed

Sponsor
CollaGenex Pharmaceuticals
Start
Mar 2007
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of oracea in rosacea, sponsored by CollaGenex Pharmaceuticals. Started Mar 2007; status: completed.

02

Drugs

oracea
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT00495313.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00495313.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call